IP Library Granted Patent US 7,005,119
Granted Patent B2
US 7,005,119 · App. 10/429,416 · Granted Feb 28, 2006

Stereoisomers of fatty acid analogs for diagnostic imaging

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,005,119
App. No.
10/429,416
Granted
Feb 28, 2006
Kind
B2
Abstract

The present invention provides novel imaging agents for clinical diagnosis of injuries and diseases, in the form of a radionuclide in spatial proximity to a substantially pure stereoisomer of a fatty acid analog. The invention also provides methods for using the novel imaging agents, and kits containing one or more of the novel imaging agents of the invention.

Claims (15)

1. A method of radio imaging cardiovascular tissue of a subject comprising administering intravenously to a subject an effective amount of pharmaceutical composition comprising:

(i) an imaging agent including a substantially pure stereoisomer of a radionuclide labeled β-methyl fatty acid analog having a formula,

R 1 (CH 2 ) n C(R 3 )HCH 2 COOR 2

 in which R 1 is selected from the group consisting of hydrogen, fluorine, an aryl group, a substituted aryl group and an iodothiophene group; R 2 is selected from the group consisting of a hydrogen, a primary amine, a secondary amine, a tertiary amine, an allyl group, a substituted alkyl group, an aryl group, and a substituted aryl group; R 3 is selected from the group consisting of a hydrogen, a methyl, a hydroxyl, a keto ester, a methoxy, a halide, and an amine and n is greater than or equal to 12; and

(ii) a chelating structure.

2. The method of claim 1 in which the chelating structure is covalently or noncovalently associated with any moiety of the imaging agent.

3. The method of claim 1 in which R 1 of the formula comprises a p-radiohalophenyl group.

4. The method of claim 3 in which the p-radiohalophenyl group is selected from the group consisting of p-radioiodophenyl and p-radiofluorophenyl.

5. The method of claim 1 in which the radionuclide labeled β-methyl fatty acid analog is 15-(p-[ 123 I]iodophenyl)-3-(R)-methylpentadecanoic acid.

6. The method of claim 1 in which the radionuclide labeled β-methyl fatty acid analog is 15-(p-[ 123 I]iodophenyl)-3-(S)-methylpentadecanoic acid.

7. The method of claim 1 in which the radionuclide labeled β-methyl fatty acid analog is 15-(p-[ 18 F]fluorophenyl)-3-(R)-methylpentadecanoic acid.

8. The method of claim 1 in which the radionuclide labeled β-methyl fatty acid analog is 15-(p-[ 18 F]fluorophenyl)-3-(S)-methylpentadecanoic acid.

9. The method of claim 1 in which the radionuclide labeled β-methyl fatty acid analog is 15-(p-[ 131 I]iodophenyl)-3-methylpentadecanoic acid.

10. The method of claim 9 in which the radionuclide labeled β-methyl fatty acid has an (R)-stereoisomeric configuration.

11. The method of claim 9 in which the radionuclide labeled β-methyl fatty acid has an (S)-stereoisomeric configuration.

Assignments (4)
RELEASE OF PATENT SECURITY INTEREST Recorded Jan 18, 2013
From: NEXBANK, SSB (AS COLLATERAL AGENT)
To: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 029660/0618 →
MERGER Recorded Jun 6, 2011
From: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
To: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 026396/0273 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded May 26, 2011
From: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
To: NEXBANK, SSB, A TEXAS-CHARTERED SAVINGS BANK, AS COLLATERAL AGENT
Reel/Frame 026347/0233 →
TERMINATION AND RELEASE OF GRANT OF SECURITY INTEREST IN PATENT RIGHTS Recorded May 23, 2011
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (F/K/A THE BANK OF NEW YORK TRUST COMPANY, N.A.)
To: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 026328/0309 →